News Archive
Takeda Pharmaceutical Company Limited today announced the completion of the study to fulfill the post-marketing commitment and submissions of data to regulatory authorities from the Pan European Multi-Database Bladder Cancer Risk Characterization Study, a large (n= 112,674), multi-database retrospective matched cohort study, conducted in four European countries, for pioglitazone containing medicines, including ACTOS with up to 10 years of follow-up.
The National Institutes of Health has awarded Georgia State University with a five-year grant to start a new Center for Excellence in Health Disparities Research, which will investigate health disparity issues in Atlanta's urban environment.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial to evaluate the ability of torezolid to penetrate into the lung for potential use to treat lung infections. In this study a 200 mg dose of torezolid phosphate was administered orally once-daily for three days to healthy adult volunteers. The trial achieved its primary goal of establishing the steady-state plasma pharmacokinetics and distribution of active drug into epithelial lining fluid (ELF).
A group of doctors from across the UK have expressed fears that the careers of 10,000 junior doctors could be irreparably damaged because of the disastrous mistakes in the Medical Training and Application Service (MTAS).
› Verified 1 days ago